HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk

INTRODUCTION: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) may lead to severe fetal or neonatal bleeding and/or perinatal death. Maternal alloantibodies, targeted against fetal human platelet antigens (HPAs), can result thrombocytopenia and bleeding complications. In pregnancies with known...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkelhorst, Dian, de Vos, Thijs W, Kamphuis, Marije M, Porcelijn, Leendert, Lopriore, Enrico, Oepkes, Dick, van der Schoot, C Ellen, de Haas, Masja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375633/
https://www.ncbi.nlm.nih.gov/pubmed/32690731
http://dx.doi.org/10.1136/bmjopen-2019-034071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375633/
https://www.ncbi.nlm.nih.gov/pubmed/32690731
http://dx.doi.org/10.1136/bmjopen-2019-034071

Ejemplares similares